End-of-life targeted auxin-mediated degradation of DAF-2 Insulin/IGF-1 receptor promotes longevity free from growth-related pathologies

  1. Richard Venz
  2. Tina Pekec
  3. Iskra Katic
  4. Rafal Ciosk
  5. Collin Yvès Ewald  Is a corresponding author
  1. Swiss Federal Institute of Technology in Zurich, Switzerland
  2. Friedrich Miescher Institute, Switzerland
  3. University of Oslo, Norway
1 additional file

Additional files

All additional files

Any figure supplements, source code, source data, videos or supplementary files associated with this article are contained within this zip.

https://cdn.elifesciences.org/articles/71335/elife-71335-supp-v1.zip

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Richard Venz
  2. Tina Pekec
  3. Iskra Katic
  4. Rafal Ciosk
  5. Collin Yvès Ewald
(2021)
End-of-life targeted auxin-mediated degradation of DAF-2 Insulin/IGF-1 receptor promotes longevity free from growth-related pathologies
eLife 10:e71335.
https://doi.org/10.7554/eLife.71335